As much as $135 million in value will be unlocked as stock of five companies eligible for trading as their shareholder ...

Medical and pharmaceutical innovation slows down in Europe, with a decline in patent applications submitted in 2024, a new ...

The broader market continued displaying mixed trends with the Nifty Midcap 100 gaining 0.2 percent and Smallcap 100 falling 0 ...

As we head into the home stretch of the 2025 legislative session, pressure mounts to protect patient care, hospitals and ...

Ireland’s largest sustainability celebration marks 17 years of excellence with 280 entries from 140 companies competing for ...

Greetings and welcome to the X4 Pharmaceuticals fourth quarter and full year 2024 financial and operating results conference call. (Operator Instructions) and it is now my pleasure to turn to your ...

From spinning out Takeda’s China assets to acquiring South Korea’s Hugel, CBC is building a global M&A engine with execution at its core.

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we are going to look at where Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) ...

Activist investor Keith Meister will join the board of gene-sequencing maker Illumina , and current board member Scott ...

On 'The Adam Carolla Show' podcast, healthcare industry watchdog and wellness expert Calley Means shares why he believes the left used to question pharmaceutical companies, big institutions, and war ...

As Robert F. Kennedy Jr. settles into his role as President Donald Trump’s health secretary, one major promise he’s made is ...

Merck (MRK) has signed a licensing agreement for a heart disease drug developed by a Chinese company in a deal worth up to $2 billion, the ...